Literature DB >> 7868813

Ontogeny of the circadian rhythm in medial basal hypothalamic beta-endorphin content in female rat.

M Criscuolo1, C De Gaetani, G Ficarra, R E Nappi, M Migaldi, F Petraglia, A R Genazzani, G P Trentini.   

Abstract

The present study evaluated the possible role of estrogens in generating the circadian rhythm of medial basal hypothalamus content at the time of puberty in female rats. Accordingly, changes in medial basal hypothalamus beta-endorphin (beta-EP) content were investigated in female rats, before and at puberty. Groups of intact or ovariectomized rats were studied after estradiol-benzoate or placebo treatment. The results showed that circadian rhythm of beta-EP content of medial basal hypothalamus is absent in prepubertal rats, while it appears at puberty, associated to a significant increase of beta-EP concentration. The primary involvement of steroids in generating this circadian rhythm was supported by the finding that estradiol-benzoate treatment caused a precocious appearance of beta-EP hypothalamic diurnal changes in prepubertal rats. Moreover, estradiol-benzoate replacement restored the loss of beta-EP nocturnal increase induced by ovariectomy in pubertal animals. Therefore, these data support the significant role of estrogen in inducing the circadian rhythm of beta-EP content in medial basal hypothalamus at the time of puberty in female rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7868813     DOI: 10.1007/bf03347761

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies.

Authors:  F Bloom; E Battenberg; J Rossier; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

Review 2.  The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides.

Authors:  M Ferin; D Van Vugt; S Wardlaw
Journal:  Recent Prog Horm Res       Date:  1984

3.  Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat.

Authors:  C A Leadem; S V Yagenova
Journal:  Neuroendocrinology       Date:  1987-02       Impact factor: 4.914

4.  Estradiol regulation of proopiomelanocortin gene expression and peptide content in the hypothalamus.

Authors:  S L Treiser; S L Wardlaw
Journal:  Neuroendocrinology       Date:  1992-02       Impact factor: 4.914

5.  The juvenile-peripubertal transition period in the female rat: establishment of a diurnal pattern of pulsatile luteinizing hormone secretion.

Authors:  H F Urbanski; S R Ojeda
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

6.  Changes in the beta-endorphin content of discrete hypothalamic nuclei during the estrous cycle of the rat.

Authors:  N Barden; Y Mérand; D Rouleau; M Garon; A Dupont
Journal:  Brain Res       Date:  1981-01-12       Impact factor: 3.252

7.  Regulation of luteinizing hormone secretion in prepubertal male and female rats.

Authors:  R Schulz; A Wilhelm; K M Pirke; A Herz
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

8.  Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels.

Authors:  J N Wilcox; J L Roberts
Journal:  Endocrinology       Date:  1985-12       Impact factor: 4.736

9.  Changes in photoperiod alter the daily rhythms of pineal melatonin content and hypothalamic beta-endorphin content and the luteinizing hormone response to naloxone in the male Syrian hamster.

Authors:  A C Roberts; N D Martensz; M H Hastings; J Herbert
Journal:  Endocrinology       Date:  1985-07       Impact factor: 4.736

10.  Changes in beta-endorphin content in discrete areas of the hypothalamus throughout proestrus and diestrus of the rat.

Authors:  U A Knuth; G S Sikand; F F Casanueva; V Havlicek; H G Friesen
Journal:  Life Sci       Date:  1983-10-10       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.